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Background and Objectives: This study assessed vitamin D status and its determinants in a cohort of octoge-
narians living within New Zealand’s Bay of Plenty and Lakes Districts. Methods and Study Design: Serum 25-
hydroxyvitamin D [25(OH)D] concentration was measured in 209 Māori (aged 80-90 years) and 357 non-Māori 
(85 years), along with demographic, lifestyle, supplement use and other health data. Results: Mean [95% CI] 
25(OH)D concentration was 69 [67 to 72] nmol/L, with 15% >100 nmol/L and 6 individuals >150 nmol/L. Con-
centrations in Māori (59 [55 to 62] 4 nmol/L) were lower than in non-Māori (75 [72 to 78] nmol/L; p<0.001), a 
difference maintained when adjusted for day-of-year measured. Vitamin D supplementation was reported by 98 
participants (18%): including a greater proportion of women (24%) than men (11%; p<0.001) and of non-Māori 
(24%) than Māori (7%; p<0.001). Of those taking vitamin D, 49% took high oral doses (≥25 µg/day or equiva-
lent) and five individuals took >50 µg/day. Vitamin D supplement use strongly and independently predicted sea-
sonally-adjusted 25(OH)D concentration and was associated with 28 nmol/L higher levels than non-use. Other 
predictors included Māori ethnicity (10 nmol/L lower concentration than for non-Māori), and female gender (11 
nmol/L lower). Conclusions: Vitamin D status in New Zealand octogenarians appears higher than previously re-
ported, particularly in non-Māori compared to Māori. Prescribed and non-prescribed oral vitamin D supplementa-
tion is prevalent in this group and a strong indicator of vitamin D status. 
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INTRODUCTION 
Low vitamin D status has been linked to a wide range of 
prevalent medical conditions with serious consequences for 
older people. These conditions include osteoporosis, falls, 
fractures, cardiovascular disease, cancer (particularly colo-
rectal) and diabetes.1 Vitamin D status in healthy adult 
populations is determined largely by exposure of the skin 
to direct ultraviolet sunlight in the B spectral range.2 In-
take from supplements, fortified foods, and a small num-
ber of foods in which vitamin D is naturally occurring 
may also play a role, and intake has been shown to pre-
vent severe deficiency when serum 25-hydroxyvitamin D 
[25(OH)D] concentration is low, as in winter.3 
Older people commonly have low circulating levels of 
25(OH)D.4  This is due to a combination of factors 
including reduced outdoor time, increased clothing cover,5 
deliberate avoidance of direct sun exposure, and reduced 
epidermal synthesis of pre-vitamin D.6 Octogenarians are 
likely to have very low serum 25(OH)D concentrations and 
an increased risk from adverse health outcomes. Lower 
concentrations have been documented in those ≥80 years 
compared to those 60-79 years in a 1988-1994 US national 
survey,7 and in Auckland women ≥80 years whose serum 
25(OH)D was 7 nmol/L lower than women aged ≥55 
 
 
years.8,9 
Vitamin D status is relatively poor in New Zealand 
(populated between latitudes 34 and 47°S) despite a 
temperate climate, 25(OH)D concentration being 
approximately 20 nmol/L lower in New Zealand and the 
UK8,10,11 than in Canada and the US.7,12 Higher North 
American levels probably result from mandatory fortifica-
tion of milk,10 but may also reflect temporal and regional 
differences in the prevalence of vitamin D supplement use. 
Differences between studies of vitamin D status may also 
result from the use of different assays13 or because of un-
even distribution of measurements throughout the year. 
Substantial seasonal variation in 25(OH)D concentration 
has been noted,14-16 with decreased winter levels arising 
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from lower solar zenith angle and reduced outdoor sun 
exposure to bare skin.2 
Although many large cohort studies, such as Longitu-
dinal Aging Study Amsterdam (LASA), Osteoporotic 
Fractures in Men Study (MrOS), Uppsala Longitudinal 
Study of Adult Men (ULSAM), and the UK National Diet 
and Nutrition Survey: 65 years and over (NDNS 65+) 
have investigated vitamin D status in healthy populations 
of predominantly Caucasian people 65 years and older,17-
20 much less data exist about status in healthy adults >80 
years old or other ethnic groups.  
Determinants of vitamin D status for cohorts >80 years 
are unclear. In younger cohorts, men generally display 
higher 25(OH)D concentration than women.21 In addition, 
vitamin D status correlates with various health and life-
style factors: positively with physical activity8,22-24 and 
self-reported health status25 and inversely with obesity24,26 
and frailty (when 25(OH)D concentration is <75 nmol/L). 
27,28 It is unclear whether the same predictors of vitamin D 
status apply for cohorts >80 years of age. 
Darker skin pigmentation screens ultraviolet light from 
the innermost strata of the epidermis, which contain the 
highest concentrations of the vitamin D precursor 7-
dehydrocholesterol.29 Correspondingly, African Ameri-
cans have lower vitamin D status than White Americans, 
with Hispanic Americans showing intermediate concen-
trations of 25(OH)D,7,30 and from a global perspective 
darker skin pigmentation is recognised as a risk factor for 
vitamin D insufficiency or deficiency.31 In New Zealand, 
whilst vitamin D status has been shown to be lower, and 
insufficiency more common in Māori compared to non-
Māori adults10 and children,32 there is no knowledge about 
the degree of vitamin D insufficiency or its correlates in 
Māori in advanced age. The aims of this study were to 
establish vitamin D status, as well as its correlates and 
determinants in Māori and non-Māori >80 years of age, 
based on measurements of serum 25(OH)D concentration. 
 
MATERIALS AND METHODS 
Recruitment 
Data for the study came from participants in the Life and 
Living in Advanced Age: a Cohort Study in New Zealand 
(Te Puāwaitanga o Nga Tapuwae Kia Ora Tonu) LiLACS 
NZ.  Māori aged 80-90 years and non-Māori aged 85 
years living within the defined district health board areas 
of Bay of Plenty and Rotorua Lakes (excluding Taupo) 
were recruited throughout the year from January to De-
cember, 2010, using an ethically-approved population-
based recruitment strategy detailed previously. 33,34 There 
was a slight lull in recruitment during summer months, 
particularly for non-Māori. In brief, all potential partici-
pants were identified from the electoral role, primary 
health care databases, word of mouth, or invited by 
someone known to them, usually the general practitioner 
or through Māori networks. Ethical approval for the study 
was granted by the New Zealand Northern X Health and 
Disability Ethics Committee (NTX/09/09/088 and 10/12/ 
127). 
Extensive efforts throughout the planning and imple-
mentation of this study were made to develop and main-
tain communication with study participants and their 
communities, and to honour the wairua/spirit of blood, 
which according to Māori tradition lives on after donation 
or death.34,35 
 
Interview & vitamin D supplement use 
Participants were interviewed by research-trained inter-
viewers using standardised methods and completed either 
a comprehensive interview about health, social, cultural 
and environmental factors or a brief interview of core 
questions. Socio-demographic characteristics were as-
sessed using adapted items from the 2006 New Zealand 
Census and deprivation index assigned from the partici-
pant’s address at the time of interview. 
For those opting to complete the full questionnaire, 
trained research nurses conducted a physical assessment 
including grip strength, height, weight, and body compo-
sition, and collected a blood sample. Medications and 
supplements were viewed to confirm reported use and 
total vitamin D dose was calculated. 
 
Body composition, physical activity & health status 
measurements 
Stature was measured in duplicate (or triplicate if varia-
tion >1 cm) using a Seca 213 free-standing stadiometer 
[Seca, Hamburg, Germany]. Body mass and percent fat 
were assessed via footplate bioelectrical impedance using 
Tanita Innerscan Body Composition Monitor, BC-545 
[Tanita Corporation, Tokyo, Japan]. Grip strength was 
measured using a Takei digital handgrip dynamometer-
Grip D. All participants completed a subset of items from 
the Nottingham Extended Activities of Daily Living 
Scale,36 which were scored positively if respondents indi-
cated that they were able to complete the activity alone, to 
produce a score out of 10. For those who completed the 
full questionnaire, level of physical activity was assessed 
using Physical Activity Scale for the Elderly,37 and 
health-related quality of life was determined using the 
physical and mental component composite scores of the 
Medical Outcomes Study Short Form Health Survey (SF-
12) and reported as standardised scores.38 
 
Blood collection 
Following an overnight fast, blood was collected by the 
research nurse at the participants’ residence or using local 
laboratory services. Samples were stored temporarily at -
20° C then at -80° C and were transported on ice or dry 
ice. Blood samples were analysed using isotope dilution 
high-performance liquid chromatography (HPLC)-tandem 
mass spectrometry for serum 25(OH)D and BioRad Vari-
ant HPLC for glycated haemoglobin (HbA1c) at Canter-
bury Health Laboratories, which participates in the Vita-
min D External Quality Assessment Scheme. Other as-
says, including cholesterol, lipids, glucose, creatinine and 
parathyroid hormone (PTH) were analysed via an auto-
mated HPLC Abbott Architect assay. 
 
Seasonal adjustment of 25-hydroxyvitamin D concentra-
tion 
In order to determine if sufficient seasonal variation in 
this cohort indicated seasonal-adjustment of levels, four 
repeated measures ANOVA models testing for the effect 
of month of blood collection were performed for Māori 
and non-Māori men and women separately in those not 
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taking vitamin D supplements. 
Methods for individual seasonal adjustment of 
25(OH)D concentrations have been described previously 
in detail39 and validated in separate cohorts.40 In summary, 
the seasonal trend for each gender/ethnic group separately 
was determined by fitting sine curves to the relationship 
between 25(OH)D against day of the year using Prism 
(Graph Pad Software Inc., La Jolla, CA, USA). Using the 
amplitude and phase-shift characteristics of these four 
sinusoidal relationships an annual baseline was predicted 
for each individual, which represented the mean serum 
25(OH)D concentration expected for that person during 
the year. The following formula was applied: 
baseline = amplitude * sin(frequency * x + offset) – y 
where x was expressed as the day of the year (January 1 = 
1; December 31 = 365) and the offset represented the 
horizontal translation along the x-axis. 
 
Data analysis 
Data were analysed using SPSS Statistics Version 19 
[SPSS Inc., an IBM Company]. Serum 25(OH)D concen-
trations were categorised dichotomously at four cut-
points: 25 nmol/L, 50 nmol/L, 75 nmol/L, and 100 
nmol/L to determine prevalence of deficiency, insuffi-
ciency (two definitions) and high levels. Chi-square tests 
were used to determine gender and ethnicity differences 
in prevalence. Univariate associations between explana-
tory variables and seasonally-adjusted and unadjusted 
25(OH)D were tested using Pearsons’ or Spearman’s cor-
relation analysis. For multiple linear regression models, 
we used seasonally-adjusted 25(OH)D as a continuous 
dependent variable. Independent variables were included 
in the regression models regardless of their association 
with the dependent variable. To reduce the effects of mul-
ticollinearity, the models were assessed using the vari-
ance inflation factor (VIF). Independent variables in the 
regression with a VIF>3 were removed. The level of sig-
nificance for statistical testing was set at α=0.05. Data are 
reported as mean [95% confidence interval] unless other-
wise stated. 
 
RESULTS 
Response and participant characteristics (Figure 1) 
From a pool of 1,636 eligible participants, 937 were en-
rolled into the study (421 Māori; 56% women). Of these, 
566 agreed to the blood sample and had blood available 
for 25(OH)D analysis: 209 Māori and 357 non-Māori. 
Those with blood available for analysis were less likely 
to be Māori (p<0.001) and female (p=0.03); had higher 
educational qualifications (p=0.007); were slightly 
younger 84.8 [83.3 to 85.3] years (median [interquartile 
range; IQR]) versus 85.0 [83.0 to 85.6] years (p=0.004); 
and reported a higher ADL score 9 [8 to 10] versus 8 [6 to 
10; p<0.001] (median [interquartile range; IQR]). They 
were also less fat, 33.0 [32 to 34] percent body fat versus 
38.2 [37 to 40]% (p<0.001); had lower BMI, 27.7 [27 to 
28] kg/m2 versus 29.2 [28 to 31] kg/m2 (p=0.02); had 
higher grip strength, 24.6 [24 to 25] versus 21.9 [20 to 24] 
± 2 kg (p=0.004); reported greater physical activity levels, 
PASE score 98 [54 to 152] versus 72 [29 to 125] (median 
[IQR]; p<0.001); and had a slightly higher mental health-
related quality of life (QoL) score, 55 [54 to 56] versus 52 
[51 to 54] (p=0.02). 
For the 566 participants included in main analyses (Ta-
 
 
 
Figure 1. Numbers of eligible participants who had blood available for analysis and completed full questionnaire. M: Māori; NM: non-
Māori; ♀: female; ♂: male.  
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ble 1), women, compared to men, were less active, had a 
weaker hand-grip strength, though had a greater ADL 
score, had greater percent body fat, total and HDL choles-
terol, lower creatinine (p<0.001 for all), and reported a 
lower physical health-related QoL score (p=0.002). Māori 
compared to non-Māori were younger due to the different 
inclusion criteria (p<0.001), had a higher deprivation in-
dex (p<0.001), higher ADL score (p<0.02) and grip 
strength (p<0.01), greater percent body fat (p=0.01) and 
BMI (p<0.001), higher glucose (p=0.001), creatinine 
(p=0.01), and HbA1c (p<0.001), and lower total (p=0.04) 
and HDL cholesterol (p=0.01; Table 1). 
 
Vitamin D status 
Monthly variation in 25(OH)D was restricted to those not 
known to be taking oral vitamin D. When those taking 
vitamin D were excluded, monthly variation was present 
only for Māori men (p=0.01) and non-Māori men 
(p<0.001), but not for women of either ethnicity (Figure 
2). In contrast, when analysis was completed for only 
those who reported taking vitamin D, none of the four 
demographic groups showed monthly variation (p=0.2-
0.7). As a consequence of these findings, individual 
25(OH)D levels were seasonally adjusted to reflect pre-
dicted mean annual concentration, only for Māori and 
non-Māori men not taking vitamin D. 
Unadjusted 25(OH)D concentration did not differ be-
tween men and women for the entire cohort or for analy-
ses of just Māori or non-Māori, however levels in Māori 
were 16 [12 to 21] lower than non-Māori (Table 1). Sea-
sonal adjustment did not affect the difference between 
Māori and non-Māori but resulted in increased 25(OH)D 
concentration in men, with levels 8 [3 to 13] nmol/L 
higher than in women (p=0.001; Table 1). 
Only 12 individuals (2%) recorded seasonally-adjusted 
25(OH)D concentration <25 nmol/L, 133 individuals 
(23%) were <50 nmol/L and 305 (54%) were <75 nmol/L. 
Whether seasonally-adjusted or not, 86 participants (15%) 
attained 25(OH)D concentrations >100 nmol/L, and 6 
individuals (5 if seasonally-adjusted) were >150 nmol/L. 
 
Vitamin D and calcium supplementation 
Of the 538 individuals for whom this information was 
available, 98 (18%) reported taking oral vitamin D either 
from non-prescribed supplements or listed medications. 
For those taking vitamin D, doses ranged from 2.5-82 
µg/day (100-3,288 IU/day), with almost one half (49%) 
reporting high oral doses ≥25 µg (1,000 IU) daily or 
equivalent, and five individuals reporting >50 µg (2,000 
IU) equivalent daily dose. Similarly, 89 individuals (17%) 
reported taking calcium, with doses ranging from 10-
2,560 mg/day (500 [285 to 875] median; [IQR]). 
A greater proportion of women (24%) than men (11%) 
reported taking vitamin D supplements (p<0.001). Only 
7% of Māori participants reported taking vitamin D sup-
plements, and 25% non-Māori (p<0.001). In addition to 
gender and ethnicity differences, vitamin D takers, com-
pared to non-takers, were slightly older (p<0.001), had 
lower BMI (p=0.02) and lower physical health-related 
QoL score (p=0.003), recorded lower PTH (p<0.001), 
higher creatinine (p<0.001), lower glucose (p=0.001) and 
HbA1c (p=0.03), and higher total and HDL cholesterol 
concentrations (Table 2). 
 
Vitamin D status in relation to supplementation 
Seasonally-adjusted 25(OH)D was higher in those taking 
vitamin D supplements (96 [91 to 101] nmol/L) compared 
to those not (67 [65 to 70] nmol/L), and compared to the 
28 individuals in whom supplementation status was un-
known (68 [55 to 80] nmol/L; p<0.001 for ANOVA and 
post-hoc comparisons). Prevalence of insufficiency (<50 
nmol/L) and deficiency (<25 nmol/L) was very low in 
those taking vitamin D (Table 3). 
Amongst non-vitamin-D-supplement takers, season-
ally-adjusted 25(OH)D concentration was lower in 
women compared to men (59 [56 to 62] and 75 [72 to 78] 
nmol/L respectively; p<0.001). Concentration in Māori 
were lower (61 [57 to 64] nmol/L than in non-Māori 71 
[68 to 75] nmol/L (p<0.001). Similarly, women were 
more likely to be deficient or insufficient compared to 
men (p<0.001) and Māori more likely than non-Māori to 
be insufficient (p=0.02; Table 3). For those taking vita-
min D, in contrast, there were no differences in 25(OH)D 
concentration or prevalence of insufficiency between 
Māori and non-Māori, or between genders (Table 3). 
High levels (>100 nmol/L) were present in those 
known to be taking vitamin D, as well as in those indicat-
ing no vitamin D supplementation, and in those whose 
vitamin D supplementation status was unknown (Table 3). 
Concentration above 100 nmol/L was more frequent in 
women compared to men who took vitamin D supple-
ments (p=0.03), but were more frequent in men compared 
to women who indicated not taking them (p=0.003; Table 
3). Amongst non-supplement takers, Māori were less 
likely than non-Māori to have concentrations >100 
nmol/L (p=0.01; Table 3). 
 
Correlations with demographic, blood, and health and 
lifestyle measurements 
Correlates of seasonally-adjusted 25(OH)D for the whole 
cohort included PTH (r=-0.24; p<0.001), BMI (r=-0.16; 
p<0.001), percent fat (r=-0.14; p<0.001), deprivation in-
dex (r=-0.11; p=0.008), glucose (r=-0.09; p<0.03) and 
PASE score (r=0.09; p=0.03), and creatinine (r=0.09; 
p=0.04). For analyses of Māori and non-Māori cohorts 
separately, deprivation index was not significantly corre-
lated with 25(OH)D in either group, and BMI and percent 
fat correlations only attained significance for Māori. Sta-
tistically significant correlations were largely restricted to 
those not reporting vitamin D supplementation (data not 
shown). 
 
Determinants of vitamin D status (Table 4) 
To determine the independent associations of the inter-
related explanatory variables with seasonally-adjusted 
25(OH)D and to establish models for its prediction, linear 
regression models were applied. The primary regression 
model included presence of vitamin D supplementation, 
age, gender, Māori versus non-Māori ethnicity, high dep-
rivation index (quintile 5), PASE score, BMI, and physi-
cal and mental health-related QoL scores. Percent fat, 
ADL score, maximum grip strength, and HbA1c were 
removed from models to reduce multicollinearity, as they  
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Table 1. Characteristics of participants 
 
 Women  Men  §p value  
Cohort 
 Māori Non-Māori  Māori Non-Māori  Gender Ethnicity Interaction 
N 119 180  90 177     566 
†No. taking vitamin D (%) 12 (10) 58 (32)  2 (2) 26 (15)  <0.001 <0.001 – 98 (17) 
Age (years) 82 (81-85) 85 (85-85)  82 (81-84) 85 (85-85)  0.5 <0.001 – 85 (84-85) 
Deprivation index 8 (6-10) 6.5 (4-8)  8 (6-10) 6 (4.5-8)  0.7 <0.001 – 7 (5-9) 
25(OH)D (nmol/L) 59±26 74±31  58±27 76±29  0.8 <0.001 0.5 69±30 
‡Adjusted Not adjusted Not adjusted  66±23 81±27  0.003 <0.001 1.0 72±29 
Blood biomarkers 
PTH (pmol/L) 5.1±2.6 4.8±2.4  4.7±2.4 4.9±3.0  0.6 1.0 0.3 4.9±2.6 
Creatinine (µmol/L) 86±24 78±21  111±37 105±34  <0.001 0.01 0.7 93±32 
Glucose (mmol/L) 5.8±1.6 5.3±0.9  5.9±1.6 5.5±0.9  0.1 <0.001 0.7 5.6±1.2 
HbA1c (mmol/mol) 41±9 37±6  41±12 37±8  0.7 <0.001 0.6 39±9 
Total cholesterol (mmol/L) 5.2±1.2 5.6±1.0  4.6±1.0 4.7±1.0  <0.001 0.04 0.1 5.1±1.1 
HDL cholesterol (mmol/L) 1.6±0.4 1.7±0.4  1.4±0.4 1.4±0.3  <0.001 0.01 0.2 1.5±0.4 
Triglyceride (mmol/L) 1.5±0.6 1.5±0.8  1.4±0.9 1.3±0.7  0.1 0.8 0.6 1.4±0.7 
Health & lifestyle factors 
PASE score 94 (52-134) 84 (40-128)  116 (53-205) 112 (63-172)  <0.001 0.2 – 98 (54-152) 
ADL score 10 (9-10) 9 (8-10)  9 (8-10) 9 (8-10)  <0.001 0.02 – 9 (8-10) 
Grip strength (kg) 20±5 18±4  32±7 30±6  <0.001 0.01 0.8 25±8 
Percent fat 37±7 37±7  31±8 28±6  <0.001 0.01 0.02 33±8 
Body mass index (kg/m2) 29±6 27±4  30±5 27±4  0.1 <0.001 0.04 28±5 
SF12-PHRQoL 43±12 39±12  45±11 44±12  0.002 0.1 0.2 42±12 
SF12-MHRQoL 54±9 55±8  54±8 55±8  0.9 0.1 0.9 55±8 
 
No.: number; 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone; PASE: Physical Activity Scale for the Elderly37; ADL: activities of daily living36; HbA1c: glycated haemoglobin; HDL: high density lipo-
protein; SF12-PHRQoL: Short Form Physical Health-Related Quality of Life standardised score38; SF12-MHRQoL: Short Form Mental Health-Related Quality of Life standardised score38. 
Data are mean±SD except for numbers of participants which are frequencies and age, deprivation index, PASE and ADL scores which are reported as median (interquartile range) due to severely non-normal distri-
bution. 
†Number who reported taking oral vitamin D supplements. 
‡Serum 25(OH)D concentrations (nmol/L) adjusted for the day of the year that blood was collected by gender and ethnicity when seasonal variation was indicated. 
§Differences via Chi-square test for frequency and 2-way ANOVA (gender x ethnicity) for continuous variables, except for age, deprivation index, PASE and ADL for which Mann-Whitney test was performed. 
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were less strongly associated with the dependent variables 
that their correlates: BMI, PASE score, gender and fast-
ing glucose. Following their removal all variables had a 
VIF<1.75. The model explained 23% of the variance in 
seasonally-adjusted 25(OH)D. Vitamin D supplementa-
tion was the strongest independent predictor (positively), 
whilst female gender, Māori ethnicity, and physical 
health-related QoL score (inversely) were also inde-
pendently associated with seasonally-adjusted 25(OH)D 
(Table 4). 
 
Figure 2. Variation in 25-hydroxyvitamin D levels [25(OH)D] by month of year for those not reporting vitamin D supplement use. Varia-
tion across months of measurement shown for A. Māori Women (p=0.08); B. non-Māori Women (p=0.2); C.; Māori men (p=0.01); D. 
non-Māori men (p<0.001). 
 
 
Table 2. Characteristics according to vitamin D supplement use 
 
 Taking (n=98) †Not taking (n=440) ‡Difference (p value) 
No. females: males 70:28 217:223 <0.001 
No. Māori: non-Maori 84:14 182:258 <0.001 
Age (years) 85.0 (84.7-85.4) 84.9 (82.8-85.3) 0.001 
Deprivation index 7 (5-8) 7 (5-9) 0.2 
25(OH)D (nmol/L) 96 (80-110) 63 (44-82) <0.001 
§Adjusted Not adjusted 67 (48-85) <0.001 
PTH (pmol/L) 42 (3.0-4.9) 5 (3.3-5.6) <0.001 
Creatinine (µmol/L) 82 (67-91) 96 (74-109) <0.001 
Glucose (mmol/L) 5.3 (4.8-5.5) 5.6 (4.9-5.8) 0.001 
HbA1c (mmol/mol) 36.8 (33.0-40.0) 38.9 (34.0-41.0) 0.03 
Total cholesterol (mmol/L) 5.5 (4.9-6.1) 5.0 (4.2-5.6) <0.001 
HDL cholesterol (mmol/L) 1.7 (1.6-1.9) 1.5 (1.2-1.8) 0.003 
Triglyceride (mmol/L) 1.4 (1.0-1.6) 1.4 (1.0-1.7) 0.7 
PASE score 88 (53-141) 101 (54-159) 0.2 
ADL score 9 (8-10) 9 (8-10) 0.4 
Grip strength (kg) 21.0 (15.1-26.4) 25.4 (18.9-31.6) <0.001 
Percent fat 33 (29-39) 33 (27-39) 0.5 
Body mass index (kg/m2) 26.4 (23.9-28.5) 28.0 (24.9-30.3) 0.002 
SF12-PHRQoL 39 (31-48) 43 (34-53) 0.003 
SF12-MHRQoL 54 (50-59) 55 (50-61) 0.2 
 
No.: number; 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone; PASE: Physical Activity Scale for the Elderly37; ADL: activi-
ties of daily living36; HbA1c: glycated haemoglobin; HDL: high density lipoprotein; SF12-PHRQoL: Short Form Physical Health-Related 
Quality of Life standardised score38; SF12-MHRQoL: Short Form Mental Health-Related Quality of Life standardised score38. 
Data are mean (95% confidence interval) except for numbers of participants which are frequencies and Age, Deprivation Index, PASE and 
ADL score which are reported as median (interquartile range). 
†Participants who received a full interview but did not indicate vitamin D use. 
‡Differences via Chi-square test for frequency, t-test for continuous variables except for age, deprivation index, PASE and ADL for which 
Mann-Whitney test was performed.  
§Serum 25(OH)D (nmol/L) concentration adjusted for the day of the year that blood was collected by gender and ethnicity when seasonal 
variation was indicated. 
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Because it may be useful to predict costly 25(OH)D 
concentration measurements from other routinely-
measured blood variables an additional analysis included 
PTH, total and HDL-cholesterol, triglyceride and glucose 
measurements in addition to the above variables. Vitamin 
D supplementation, creatinine, and HDL-cholesterol 
(positively) and PTH, Māori ethnicity, and female gender 
inversely attained independent association with season-
ally-adjusted 25(OH)D and cumulatively explained 29% 
of its variance (data not shown). 
Female gender and Māori ethnicity (inversely) and 
PASE (positively) were significant predictors of season-
ally-adjusted 25(OH)D when analysis was restricted to 
those not taking vitamin D. For Māori and non-Māori 
Table 3. Prevalence of vitamin D deficiency [†25(OH)D <25 nmol/L], insufficiency [†25(OH)D <50 nmol/L and <75 
nmol/L], and high levels [†25(OH)D >100 nmol/L] according to vitamin D supplement use in Māori and non-Māori 
 
 Women  Men  ‡p value ‡p value 
 Maori Non-Maori  Maori Non-Maori  Gender Ethnicity 
Taking vitamin D n=12 n=58  n=2 n=26   
<75 nmol/L 1 (8) 12 (21) 1 (50) 3 (12) 0.6 0.7 
<50 nmol/L 0 (0) 2 (3) 0 (0) 0 (0) 0.4 0.6 
<25 nmol/L 0 (0) 0 (0) 0 (0) 0 (0) – – 
>100 nmol/L 4 (33) 28 (48) 0 (0) 6 (23) 0.03 0.4 
        
Not taking vitamin D n=102 n=115  n=80 n=143   
<75 nmol/L 82 (80) 58 (73) 51 (64) 62 (43) <0.001 <0.001 
<50 nmol/L 44 (43) 38 (48) 18 (23) 19 (13) <0.001 0.02 
<25 nmol/L 6 (6) 5 (6) 1 (1) 0 (0) 0.009 0.06 
>100 nmol/L 4 (4) 9 (11) 6 (8) 25 (17) 0.003 0.01 
        
Unknown n=5 n=7  n=8 n=8   
<75 nmol/L 4 (80) 2 (29) 7 (88) 3 (38) 0.5 0.006 
<50 nmol/L 2 (40) 1 (14) 3 (38) 2 (25) 0.7 0.3 
<25 nmol/L 0 (0) 1 (14) 0 (0) 1 (13) 0.8 0.2 
>100 nmol/L 0 (0) 2 (29) 13 (2) 2 (25) 0.9 0.2 
 
Data show number of individuals (percentage of gender/ethnicity category). 
†Serum 25-hydroxyvitamin D [25(OH)D] concentrations for males not taking vitamin D are adjusted for season of measurement.  
‡Level of statistical significance of difference in frequencies by gender and ethnicity from Chi-square test. 
 
 
Table 4. Determinants of 25(OH)D adjusted for the day-of-year of measurement (seasonally-adjusted) 
 
 n Predictors β-coefficient SE β p 
Whole cohort  
 519 VitD supp 27.9 3.0 <0.001 
  Female gender -11.0 2.4 <0.001 
  Māori ethnicity -10.4 3.1 0.001 
  Physical QoL -0.22 0.11 0.04 
  PASE 0.033 0.018 0.06 
  BMI -0.47 0.26 0.07 
  MODEL r2 = 0.23    
Not taking vitamin D†  
 422 Female gender -13.9 2.5 <0.001 
  Māori ethnicity -11.2 3.2 <0.001 
  PASE 0.036 0.018 0.0498 
  Age -1.29 0.74 0.08 
  MODEL r2 = 0.14    
Māori – not taking vitamin D‡  
 172 Female gender -10.2 3.6 0.006 
  Age -1.37 0.71 0.05 
  BMI -0.62 0.34 0.07 
  MODEL r2 = 0.10    
Non Māori – not taking vitamin D‡  
 250 Female gender -16.5 3.5 <0.001 
  PASE 0.051 0.028 0.07 
  Physical QoL -0.29 0.17 0.08 
  MODEL r2 = 0.12    
 
Predictor variables include presence of vitamin D supplementation (VitD supp), gender (female versus male), ethnicity (Māori versus non-
Māori), age, high deprivation index (quintile 5), body mass index (BMI), physical activity score (PASE) ,37 physical health composite 
quality of life T-score (Physical QoL),38 mental health composite quality of life T-score.38 
†Vitamin D supplementation removed from model. 
‡Vitamin D supplementation and ethnicity removed from model. 
Percent fat, activities of daily living score, grip strength and HbA1c were removed from all models due to high correlation with BMI, 
PASE score, gender and glucose respectively; lower predictive power on dependent variables than related variables; as well as improved 
collinearity statistics following their removal. 
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separately, only female gender (inverse predictor) at-
tained statistical significance for prediction of seasonally-
adjusted 25(OH)D. 
 
DISCUSSION 
Vitamin D status 
From this study, we set out to determine vitamin D status 
of a cohort of Māori and non-Māori octogenarians, resid-
ing in the central North Island of New Zealand. Similar 
data from octogenarians, are relatively rare compared to 
slightly younger cohorts, and almost non-existent for 
Māori. 
Overall, levels here are 20 nmol/L higher than those 
reported previously in older adults in New Zealand8,10 and 
the UK.11 Mean levels of 25(OH)D of 43 nmol/L for 
women and 55 nmol/L for men in those ≥65 years were 
observed in New Zealand in the 1997 National Nutrition 
Survey;10 51 nmol/L in postmenopausal women aged 74±4 
years (mean±SD) living in the greater Auckland region;8 
and levels of 52 nmol/L in 50-64 year olds in the UK.11 In 
fact, the higher levels (72 nmol/L for seasonally-adjusted 
levels) in the present study are very similar to levels previ-
ously reported from North American surveys: in those ≥60 
years in NHANES III7 or in 60-79 year olds in Canada.12 
Furthermore, the prevalence of deficiency is low. For those 
not taking vitamin D supplements, only 11 women and a 
single man in this group were vitamin D deficient 
(25(OH)D<25 nmol/L) and most displayed seasonally-
adjusted levels >50 nmol/L. 
Different assay use or uneven distribution of measure-
ments throughout the year may explain differences in 
vitamin D status between surveys. Assay inconsistency 
may explain, in part, the difference in 25(OH)D levels 
reported between the 1997 survey,10 derived from Di-
asorin radioimmunoassay and the current study, which 
reports HPLC-MS assay data. Whilst past studies indicate 
that Diasorin RIA results are comparable to LC-MS as-
says,13,41 differences of the magnitude reported here can-
not be entirely discounted. 
Our data show that vitamin D supplementation limited 
seasonal fluctuation in this cohort. Longitudinal seasonal 
variation in 25(OH)D levels has previously been demon-
strated in older people,42,43 particularly those with low 
oral vitamin D intakes.44 In the present study, we failed to 
show significant annual variation in women not on vita-
min D. This is in contrast to past differences between 
summer peak and winter nadir of between 25 and 28 
nmol/L that have been shown cross-sectionally in older 
women in Auckland (37°S)8 and Southeastern Australia 
(38-39°S),45 when those taking high-dose vitamin D sup-
plements were excluded. In line with our findings of sea-
sonal variation in men’s 25(OH)D levels, an Auckland 
study showed large peak – nadir differences of 40 nmol/L 
in men aged ≥40 years.23 and a more recent study without 
this exclusion criterion reported seasonal differences of 
only 16 nmol/L, in independently-living Australian men 
aged ≥70 years.24 
Of note, we have reported that several participants had 
high levels of 25(OH)D. Because skin production of vita-
min D is self-limiting,46 it seems likely that these levels 
resulted from over-supplementation, possibly caused by the 
use of multiple vitamin-D-containing products or because 
the practice of prescribing infrequent high-dose vitamin D 
may not have been apparent from the study assessment.  
 
Generalisability of findings 
Several factors may have resulted in over-estimation of 
25(OH)D levels in this study, compared to all those eligible 
or to the wider population of octogenarians. Firstly, it is 
possible that those not agreeing to take part in the study or 
provide blood samples differed in vitamin D status from 
those agreeing. Blood samples were obtained in 35% of all 
people eligible for the study according to the electoral roll. 
Furthermore, those agreeing to provide blood reported less 
difficulty with performing daily living tasks independently, 
and were younger, leaner, and more active than those not 
providing blood, and thus may also have had greater expo-
sure to outdoor sunlight and higher 25(OH)D concentration 
than the population at large. While it is not possible to esti-
mate the effect size of this response bias on reported vita-
min D status, the response rate here is higher than the effec-
tive response rate of ≈23% for New Zealanders ≥65 years in 
the 1997 survey, from whom mean 25(OH)D concentra-
tions around 20 nmol/L lower were reported.10 Secondly, 
these Central North Island regions of New Zealand are 
sunny areas and people residing here might be expected to 
have higher than average vitamin D status. 
In contrast to the possibility of over-estimation, the over-
sampling of Māori versus non-Māori people in this study 
might underestimate 25(OH)D, since levels in Māori were 
lower than in non-Māori. A broader age range of Māori 
compared to non-Māori, was recruited to ensure comparable 
numbers, given a large ethnic disparity in longevity.33 Sea-
sonally-adjusted 25(OH)D in Māori was 16 nmol/L lower 
than in the combined cohort. 
 
Vitamin D status in Māori 
Lower levels of 25(OH)D have been previously reported in 
Māori compared to non-Māori10,47,48 and a higher incidence 
of deficiency (levels <25 nmol/L) noted in Māori living in a 
low socio-economic urban area.49 Scragg et al47 randomly 
selected 390 people from a large survey of workers aged 40 
to 64 years. Levels of 25(OH)D in those describing their 
ethnicity as other than Māori or Pacific Island were 7 
nmol/L higher than in those identifying as Māori, and 10 
nmol/L higher than Pacific Islanders. Vitamin D status data 
from two National nutritional surveys of adults ≥15 years 
old, conducted in 1997 and 2008 also showed levels in 
Māori to average approximately 8 nmol/L10 and 3 nmol/L48 
lower than in non-Māori respectively. Unique to the present 
study are vitamin D data from a sizable sample of Māori 
who have lived into their 80s. Here, disparity in seasonally-
adjusted 25(OH)D levels between Māori and non-Māori 
participants was much greater than in previous studies, at 
approximately 16 nmol/L. Ethnicity, but not deprivation 
index, was independently predictive of levels in regression 
models.  
The reasons for the large ethnic differences noted here 
are not completely clear. Previous studies have attributed 
lower levels of 25(OH)D in Māori compared to non-Māori 
to darker skin tone;47 higher melanin concentration blocks 
ultraviolet-dependent conversion of 7-dehydrocholesterol to 
pre-vitamin D.29 Skin tone amongst those identifying as 
Māori in New Zealand varies widely, and more recent 
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data suggest that neither natural skin colour (of the upper, 
inner arm),50 self-reported skin type,51 nor skin reflec-
tance52 are associated with vitamin D status in New Zea-
land populations. In addition to skin reflectance, 
McKenzie et al52 assessed the effect of body mass index, 
gender and ethnicity on 25(OH)D response to a standard 
full-body dose of artificial ultraviolet radiation in 201 
volunteers from Auckland and Dunedin, New Zealand. Of 
these independent variables, only ethnicity (categorised as 
European, Māori, Pacific or Asian) significantly predicted 
changes in 25(OH)D. Somewhat paradoxically, Māori 
recorded the greatest change in 25(OH)D levels and cal-
culated sensitivity relative to ultraviolet dose, 1.8x higher 
than for Europeans. Potentially, whatever the underlying 
cause of lower vitamin D status in Māori applies across a 
broad age range and accumulates with advanced years. 
In some population studies, age has been shown to be 
inversely related to 25(OH)D levels,8,10 with declines in 
levels particularly at ages >80 years, and in women more 
than men.23 Age was not a significant predictor of vitamin 
D status in the present study. In any case, age differences 
would not explain differences in vitamin D status with 
ethnicity reported here since Māori, being on average 3 
years younger than non-Māori because of the different 
inclusion criteria, would be expected to have had higher, 
not lower levels of 25(OH)D. In addition, Māori indicated 
greater functional independence, with higher ADL score 
and grip strength, also ordinarily connected with higher, 
rather than lower, levels of 25(OH)D in elderly.8,23 One 
possible reason for the larger difference in vitamin D 
status with ethnicity reported here might be changing 
societal attitudes over recent years regarding self-
perception of Māori ethnicity. It is possible that these 
changing attitudes may have resulted in a broader cross-
section of people identifying as Māori and thus a reduc-
tion in ethnic differences in vitamin D status. This effect 
might be greater for younger age-groups than for people 
in their 80s. 
Although 25(OH)D levels were lower in Māori than 
non-Māori, only 2.9% of Māori were vitamin D deficient 
(<25 nmol/L) and 21% insufficient (<50 nmol/L), com-
pared to 1.7% and 16% of non-Māori. The skeletal and 
other health consequences of this are unclear, particularly 
for Māori. There is substantial uncertainty about optimal 
levels of 25(OH)D. Whilst some in the field argue 
strongly in favour of minimum reference levels of 75-80 
nmol/L,53-55 others have questioned the reliance for these 
conclusions on observational data and maintain that suffi-
cient evidence justifies only a minimum reference level of 
50 nmol/L.56-58 Moreover, it is not clear whether the effect 
of 25(OH)D on skeletal health is consistent across differ-
ent ethnic groups. Two studies have demonstrated para-
doxical inverse associations between 25(OH)D and indi-
ces of bone morphology and strength in older men,59 and 
fracture risk in older women of African American de-
scent.60 A recent study has also identified lower levels of 
vitamin D binding protein in older black Americans, sug-
gesting that lower serum 25(OH)D may have less effect 
on bioavailability than in white counterparts.61 In New 
Zealand, fracture rates are lower for Māori than non-
Māori,62 despite these apparent differences in vitamin D 
status. 
Determinants of vitamin D status 
Vitamin D supplement use was the strongest determinant 
of 25(OH)D levels and prevalence of vitamin D supple-
ment use was an important reason for differences in vita-
min D status between Māori and non-Māori. With correc-
tion for other predictors, those taking supplements had 
25(OH)D levels 27-30 nmol/L higher than those not. Fur-
thermore, there were no differences between Māori and 
non-Māori in 25(OH)D levels or insufficiency prevalence 
for those taking vitamin D supplements. Nonetheless, in 
models containing supplement use, Māori ethnicity still 
independently explained variance in 25(OH)D levels, 
with Māori being 10-12 nmol/L lower than non-Māori 
when other variables were accounted for in the model. 
Thus, it appears that approximately a third of the differ-
ence between Māori and non-Māori is due to differences 
in vitamin D supplement use. Shea et al63 also note the 
importance of vitamin D supplementation in vitamin D 
status of 70-81 year old Americans, particularly in those 
of African descent. The prevalence of vitamin D supple-
ment use was higher in that study with 34% and 44% of 
participants of African and Caucasian descent respec-
tively taking vitamin D, compared to 7% and 25% of 
Māori and non-Māori participants in the current study. 
In agreement with some past studies of older 
people,21,23 we found that men have higher 25(OH)D lev-
els than women when adjusted for seasonal variation. 
Physical activity levels, physical health-related QoL, and 
BMI also predicted 25(OH)D. Predictive effects of physi-
cal activity levels8,22-24 and adiposity indices8,23,24,26 are in 
agreement with previous studies investigating determi-
nants of vitamin D status in older men and women. How-
ever, in the present study, none of these variables were 
strong predictors and the associations mainly disappeared 
when the dependent variable was seasonally-adjusted, or 
for Māori 80-90 year olds. 
 
Conclusion 
In conclusion, these regional data suggest that vitamin D 
status in octogenarians in New Zealand is higher than 
comparable studies of older adults conducted 10-15 years 
ago, and appears to be associated with the use of high-
dose oral vitamin D preparations. In this group measures 
such as physical activity, body composition and quality of 
life, were not strongly predictive of vitamin D status ad-
justed for the time-of-year of measurement. Data arising 
from analysis of human tissue, including blood, is par-
ticularly scarce for Māori. Our data address this lack and 
show that levels of 25(OH)D in Māori are substantially 
lower than in non-Māori, with around a third of the dif-
ference explained by higher prevalence of vitamin D sup-
plement use amongst non-Māori. Despite this difference, 
vitamin D status of both Māori and non-Māori octoge-
narians is relatively high, even for those not on vitamin D. 
Whilst the health implications of these levels are not clear 
from cross-sectional data, our data show common use of 
high-dose vitamin D preparations in people aged in their 
80s, much of which may be obtained over-the-counter, 
and health practitioners should enquire about supplement 
use before considering vitamin D prescription. 
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新西兰毛利族和非毛利族八旬老人维生素 D状况：一项
队列研究 
 
背景与目的：本研究评估了队列研究中生活在新西兰湾和湖泊区域的八旬老人
的维生素 D 状况及其决定因素。方法与研究设计：测量 209 名毛利人（80-90
岁）和 357名非毛利人（85岁）的血清 25-羟维生素 D（25(OH)D）的浓度，同
时收集研究对象的体格测量指标、生活方式、补充剂的应用和其它健康资料。
结果：平均 25(OH)D 浓度为 69（95% CI：67-72）nmol/L，其中 15%的研究对
象>100 nmol/L，6 个研究对象>150 nmol/L。毛利人的 25(OH)D 浓度（59 
nmol/L，95% CI: 55-62 nmol/L）低于非毛利人（75 nmol/L，95% CI：72-78 
nmol/L，p<0.001），校正测量日期后，差异仍然存在。98名（占 18%）研究对
象报告补充了维生素 D，女性中补充者所占的比例（24%）高于男性（11%，
p<0.001），非毛利人中补充者所占的比例高于毛利人。补充维生素 D的人中，
49%的人摄入高剂量（每天≥25 µg或相当剂量），5个研究对象每天摄入维生素
D≥50 µg。维生素 D 补充剂的应用能够强而独立地预测季节校正的 25(OH)D 浓
度，并且使用者比不用者高 28 nmol/L。其它预测指标包括毛利族（比非毛利族
低 10 nmol/L）和女性性别（比男性低 11 nmol/L）。结论：新西兰八旬老人维
生素 D 浓度高于以前的报告，尤其是非毛利人。这个人群中处方和非处方口服
维生素 D补充剂普遍存在，并且是维生素状态的强预测指标。 
 
关键词：骨化醇、季节变化、民族、年龄在 80岁及其以上、老年人 
